Is Anakinra (Kineret) in shortage in 2026? Get the latest on availability, pricing, and what patients can do if they can't find their medication.
If you rely on Anakinra (Kineret) to manage your condition, you know that any disruption in supply can be more than an inconvenience — it can mean worsening symptoms, disease flares, and real anxiety. Whether you've heard rumors of a shortage or you're personally struggling to find it, here's a clear, up-to-date picture of Anakinra availability in 2026.
As of early 2026, Anakinra is not listed on the FDA Drug Shortage database. That means there is no officially recognized nationwide shortage of Kineret.
However — and this is important — not being in an official shortage doesn't mean it's easy to find. Anakinra is a specialty biologic medication. It's dispensed primarily through specialty pharmacy networks, not standard retail pharmacies. So even when the national supply is adequate, individual patients can still face access challenges due to:
If your pharmacy tells you they can't get Anakinra, it's more likely a distribution or access issue than a true manufacturing shortage.
Several structural factors make Anakinra harder to access than most medications:
Swedish Orphan Biovitrum (Sobi) is the sole manufacturer of Kineret. There are no generics, no biosimilars, and no alternative brands. If Sobi experiences any production or distribution hiccup, there's no backup supply.
Kineret must be kept refrigerated and is almost exclusively dispensed through specialty pharmacies. Your neighborhood CVS or Walgreens won't have it on the shelf, and trying to get it through retail channels usually leads to delays and dead ends.
Most insurance plans require prior authorization for Kineret. Many also impose step therapy — you may need documented failure on other medications before they'll approve it. These processes can take days to weeks, creating gaps in access even when the drug itself is available.
For a deeper dive, read: Why is Anakinra so hard to find?
Anakinra remains one of the more expensive biologic medications on the market:
There is no generic or biosimilar version available, so discount options are limited to manufacturer programs and patient assistance. For the full cost breakdown, see: How to save money on Anakinra.
The IL-1 inhibitor market hasn't changed dramatically, but here's what's worth knowing:
For a full comparison of alternatives, see: Alternatives to Anakinra.
If you need Anakinra today, here's your action plan:
For detailed tips, check out: How to find Anakinra in stock near you.
Anakinra isn't in an official shortage in 2026, but that doesn't mean access is simple. Between specialty pharmacy distribution, sole-manufacturer supply, and insurance hurdles, patients face real obstacles. The good news: with the right tools and a proactive approach, you can navigate these challenges.
Stay informed, plan ahead, and don't hesitate to lean on resources like Medfinder, your doctor's office, and Sobi's patient support programs. You don't have to figure this out alone.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
